Sonoma Biotherapeutics on Monday hosted a ribbon cutting ceremony at its new research and development center and office space on Seattle’s waterfront.
The biotech company, which has a second location in South San Francisco, has taken over three of four floors in a building formerly occupied by the tech company F5, spanning a total of 83,000 square feet.
Sonoma launched in 2019 and is focused on treating autoimmune and inflammatory diseases in which a person’s immune system over-responds and attacks the wrong cells. It’s pursuing treatments that use what are known as regulatory T (Treg) cells to protect the cells under attack.
Sonoma has finished remodeling one of the floors of the building on Elliott Avenue, which will bring employees who had been spread between three locations in Seattle under one roof.
